Friday, May 24, 2013

ACS Recognizes New Tanning Bed Regulations

The American Cancer Society Cancer Action Network applauds the Food and Drug Administration’s (FDA) announcement May 6, 2013, that it will reclassify tanning beds from low- to moderate-risk products 

“With today’s decision, sunlamps used for tanning will go from being regulated in the same risk category as tongue depressors to a category that more accurately reflects their danger to individuals’ health,” says RJ Ours, Colorado Director with the American Cancer Society Cancer Action Network.

Ours goes on to say, an FDA advisory panel recommended the reclassification so the public would become more aware of the dangers associated with tanning beds. “Today’s announcement will also require salons to display crucial labeling that discourages people under the age 18 from using these products,” he says.

To emphasize safety matters, if you use tanning beds before your 35th birthday, consider this. “It increases your lifetime risk of developing melanoma, the deadliest type of skin cancer, by 75 percent,” Ours adds.

Ours calls the FDA’s decision an “historic leap forward.”

And he reminds us that the American Cancer Society will keep working “at the state level to support policies that prohibit tanning bed use by minors.”

To read the official letter sent to the U.S. Department of Health and Human Services from the ACS CAN president who requested reclassification, please click this link:

No comments:

Post a Comment